Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines

Clinical Cancer Research

Volumn 7, Issue 4, 2001, Pages 1087-1093

  Lakka, Sajani S ^a   Rajagopal, Ramesh ^b   Rajan, Mannari K ^b   Mohan, Pamarthi M ^b   Adachi, Yoshiaki ^b   Dinh, Dzung H ^a   Olivero, Willaim C ^a   Gujrati, Meena ^a   Ali Osman, Francis ^b   Roth, Jack A ^b   Yung, W K Alfred ^b   Kyritsis, Athanassios P ^b   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTISENSE UROKINASE RECEPTOR; MATRIGEL; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL LYSATE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE TIME EFFECT RELATION; FEMALE; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RABBIT; RETICULOCYTE; SCID MOUSE; TREATMENT OUTCOME; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; DNA, ANTISENSE; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LUNG NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN BIOSYNTHESIS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034906667     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The urokinase receptor: Involvement in cell-surface proteolysis and cancer invasion
2. Biology and biochemistry of proteinases in tumor invasion
3. Control type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell bound reactants
4. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells
5. r 55, 000 form of the human plasminogen activator, urokinase
6. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface plasmin dependent proteolysis
7. The urokinase-type plasminogen activator system in cancer metastasis: A review
8. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue
9. Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer
10. Urokinase receptor and colorectal cancer survival
11. Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue
12. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas
13. Upregulation of urokinase and urokinase receptor genes in malignant astrocytoma
14. Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo
15. Immunohistochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma
16. The plasminogen activation system and its role in lung cancer. A review
17. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs
18. Cancer cells overexpress mRNA of urokinase type plasminogen activator, its receptor and inhibitors in human non-small cell lung cancer tissue: Analysis by northern blotting and in situ hybridization
19. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor (uPAR) suppresses glioma invasion and tumor growth
20. In vitro inhibition of human glioma cell line invasiveness by antisense uPA receptor
21. Down regulation of urokinase receptors by antisense transfection modulates human glioma cell adhesion and spreading in vitro
22. Specific regulation of gene expression by antisense, sense, and antigene nucleic acids
23. Role of urokinase receptor and caveolin in regulation of integrin signaling
24. Urokinase/urokinase receptor system: Internalization/degradation of urokinase-serpin complexes: Mechanism and regulation
25. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
26. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
27. Urokinase plasminogen activator receptor, β 2 integrins, and Src-kinases within a single receptor complex of human monocytes
28. Downstream targets of urokinase type plasminogen activator mediated signal transduction
29. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal regulated kinase 1 and 2, which is required for increased cellular motility
30. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogenactivated protein kinase in cultures of endothelial cells
31. The p16 ink4a tumor suppressor protein inhibits α VB3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of α VB3 to focal contacts
32. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors
33. Plasminogen activators, integrins and the coordinated regulation of cell adhesion and migration
34. Reduction in surface urokinase receptor forces malignant cells into protracted state of dormancy
35. Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse
36. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within the growth factor-like domain of urokinase in an experimental and spontaneous metastasis model
37. Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist
38. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice
39. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells
40. Adenovirus mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice
41. Prevention of metastasis by inhibition of the urokinase receptor
42. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy
43. Reversion of the invasive phenotype of transformed human fibroblast of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibitor of urokinase receptor gene expression
44. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
45. The urokinase-type plasminogen activator receptor (CD87) is a pleiotrophic molecule